- Home
- COEP vs POAS Comparison
COEP vs POAS Comparison
Compare COEP & POAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$14.76
N/A
Current Price
$3.30
Company Overview
Basic Information| Metric | COEP | POAS |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 114.0M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | COEP | POAS |
|---|---|---|
| Price | $14.76 | $3.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 97.1K | ★ 566.4K |
| Earning Date | 11-14-2025 | 02-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,996.00 | $128,328.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.80 | $2.90 |
| 52 Week High | $21.41 | $4.30 |
Technical Indicators
Market Signals| Indicator | COEP | POAS |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | N/A |
| Support Level | $13.88 | N/A |
| Resistance Level | $15.12 | N/A |
| Average True Range (ATR) | 0.83 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 78.91 | 0.00 |
Price Performance
Historical Comparison COEP
POAS
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.